ARX-01 Publications
Abstract Title: Single- and Repeat-Dose Pharmacokinetics of Sublingual Sufentanil NanoTab in Healthy Volunteers
Presentation: Single- and Repeat-Dose Pharmacokinetics of Sublingual Sufentanil NanoTab™ in Healthy Volunteers
Poster: A Phase 2 Open-Label Functionality, Safety, and Efficacy Study of the Sufentanil NanoTab™ PCA System in Patients Following Elective Unilateral Knee Replacement Surgery
Poster: A Phase 2 Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of Sublingual Sufentanil NanoTab™ in Patients Following Major Abdominal Surgery
Poster: A Phase 2 Open-Label Functionality, Safety, and Efficacy Study of the Sufentanil NanoTab™ PCA System in Patients Following Elective Unilateral Knee Replacement Surgery
Abstract Title: A Phase 2 Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of Sublingual Sufentanil NanoTab™ in Patients Following Elective Unilateral Knee Replacement Surgery
Abstract Title: A Phase 2 Open-Label Functionality, Safety, and Efficacy Study of the Sufentanil NanoTab™ PCA System in Patients Following Elective Unilateral Knee Replacement Surgery
Abstract Title: A Phase 2 Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of Sublingual Sufentanil NanoTab™ in Patients Following Major Abdominal Surgery
ARX-02 Publications
Abstract: Pharmacokinetics and Dose Proportionality of Sublingual Sufentanil NanoTab in Healthy Volunteers
Presentation: Pharmacokinetics and Dose Proportionality of Sublingual Sufentanil NanoTab™ in Healthy Volunteers
